-
US Mortgage Rate Falls for Fourth Week but Remains Above 7%
-
US Jobless Claims Rise to 200,000 but Layoffs Remain Historically Low
-
Fire Erupts Near MetLife Stadium After Jets-Bills Game
-
Italy Raises 2026 Growth View but Warns Energy Will Keep Inflation High
-
Euro-Area Growth Slows to 0.4% While Employment Stalls
-
UK Economy Grows 0.7% in Third Quarter as Services Lead Expansion
-
US Wholesale Inflation Eases Monthly but Hits a Four-Year Annual High
-
India's Retail Inflation Reaches 6.09% as Food Prices Accelerate
-
India's Wholesale Inflation Jumps to 12.29% as Fuel Costs Surge
-
China's October Activity Data Reveal a Weak Start to the Fourth Quarter
-
Japan's Economy Edges Into Contraction as Costly Oil Weighs on Demand
-
Philippines Urges ASEAN and China to Accelerate South China Sea Code of Conduct
-
South Korea Launches Probe into NewJeans Contract Controversy
-
Met Office Issues Yellow Snow Warning for Nottinghamshire on Tuesday
-
UK Defence Secretary Warns Russia Nukes Not for Negotiation as HMS Vengeance Returns
-
Presidio Property Trust, Inc. Announces Earnings for the Quarter Ended September 30, 2026
-
SMX Brings a New Level of Transparency to Gold Trading Through trueGold Technology
-
Westell Technologies, Inc. Announces Its Commencing a Tender Offer
-
Rescue Intellitech Expands Professional Decontamination Portfolio for Fire Departments with DeconWasher(TM) Pro S
-
MicroVision Lidar Powers Commercial Driverless Trucking at Scale with Kodiak AI
-
Expecting a Refund but Owe Back Taxes? Clear Start Tax Explains How the IRS Offset Program Takes It First
-
Ainos Reports Third Quarter 2026 Results and Highlights Expanding AI Nose Commercial Momentum
-
Cardiff Lexington Announces Third Quarter 2026 Financial Results
-
SMX: The Future of Gold Will Be Defined by What We Know About It -Powering Verified Trade and Tokenisation
-
NuRAN Wireless Eliminates Floating-Price Preferred Overhang and Locks In a Fixed C$1.20 Conversion Price
-
GameSquare Holdings Reports 2026 Third Quarter Results with Revenue up 77% YoY and Net Income Reaches $10.1 Million
-
ValorPay UAB Goes Live on T2, the Eurosystem's Real-Time Settlement System
-
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
-
XCF Global Reports Third Quarter 2026 Financial Results & Affirms 2027 Outlook
-
NextSource Materials Appoints Eugene Lee as Chief Financial Officer
-
International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results
-
Abasca Resources Engages Northern Arc Public Affairs to Advance Federal Engagement on the Loki Flake Graphite Project
-
AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins
-
Thalia Therapeutics PLC Announces Promising Interim Phase I Data for miRisten in AML
-
Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
-
Golden Minerals Reports Third Quarter 2026 Financial Results
-
OBI Pharma Signs Collaboration and License Agreement with Novartis
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 16
-
Blue Chip Capital Group Announces Quotation of its Common Stock on the OTCID and Updates Status of Initial Regulatory Compliance
-
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
-
Spartan Capital Adds Institutional Investor, Upsizes Credit Facility to $100 Million
-
Diné Development Corporation Named 2026 Minority-Owned Business of the Year by Dayton Business Journal
-
Orlando Dreamers Announce Hundreds of Millions of Additional Financing Under Initial Letter of Intent
-
How to Remotely Access a PLC? Improve Maintenance Efficiency with InHand 4G/5G Industrial Routers
-
Graid Technology Extends VROC(TM) to AMD EPYC(TM) Platforms, Expanding Choice in Enterprise RAID
-
SMX Targets the Missing Link in Global Gold Markets: Proof
-
Lifeloc Reports Third Quarter 2026 Results
-
Sharecare Integrates IDMe into AskMD, Providing Over 100 Million Americans a Seamless, Secure Way to Access Personalized Health Guidance
-
Medical Care Technologies Inc. (OTCID:MDCE) Follows Q3 Profit Surge With Confirmed Software Development and Expanding Subsidiary Activity
-
NWPG's NFI Empire Reports Third Quarter 2026 Results
Brazil's Bolsonaro tweets support for podcaster Rogan
Brazil's far-right President Jair Bolsonaro tweeted his support for embattled American podcast host Joe Rogan, whose spreading of disinformation about Covid-19 has caused a firestorm of controversy on streaming service Spotify.
The leader known as the "Tropical Trump," who has himself been accused of spreading disinformation on the pandemic, waded into the Rogan row with a rare English-language post on Twitter Wednesday.
"I'm not sure what @joerogan thinks about me or about my government, but it doesn't matter. If freedom of speech means anything, it means that people should be free to say what they think, no matter if they agree or disagree with us," Bolsonaro wrote.
"Stand your ground! Hugs from Brazil."
Rogan is at the center of an entertainment-world storm after several music superstars, including Neil Young and Joni Mitchell, ditched Spotify over its handling of Rogan's controversial statements on Covid-19 vaccines.
Rogan, an ex-martial arts champ turned hugely popular talk show host, has discouraged Covid-19 vaccination in young people and promoted the off-label use of the anti-parasitic drug ivermectin to treat the disease.
Facing a spreading backlash, Spotify announced Sunday it would start guiding podcast listeners toward factual information on the pandemic.
But it has not cut ties with Rogan, whose show, "The Joe Rogan Experience," has been broadcast exclusively on the platform since 2020, under a deal worth an estimated $100 million.
The podcast draws 11 million listeners per episode on average.
Bolsonaro has himself questioned Covid-19 vaccines, joking they could "turn you into an alligator," and touted treatments such as anti-malarial drugs chloroquine and hydroxychloroquine despite research showing they are ineffective against the disease.
D.Sawyer--AMWN